Staying Current Regarding Available Therapeutic Options and Updates to Treatment Guidelines
March 27th 2025Panelists discuss how health care professionals maintain expertise in menopause management through continuous learning via medical journals, professional networks, CME programs, digital resources, and tracking emerging research and therapeutic guidelines.
Optimizing ADC Supportive Care Prescribing and AE Management With Institutional Workflows
March 27th 2025Panelists discuss how health care professionals use standardized antibody-drug conjugate (ADC) pathways to guide dosing, adverse effect (AE) management, and transitions. Protocols ensure monitoring, toxicity mitigation, and seamless shifts between therapies for optimal care.
Monitoring Strategies for Managing ADC Toxicities in mBC
March 27th 2025Panelists discuss how pharmacists should monitor neutropenia, diarrhea, and mucositis from sacituzumab govitecan (SG); interstitial lung disease (ILD) and neutropenia from trastuzumab deruxtecan (T-DXd); and neutropenia and ILD from datopotamab deruxtecan (Dato-DXd). Proactive management is essential for patient safety.
Examining the 505(b)(2) Pathway and Implementation into EHR
March 20th 2025A panelist discusses how the 505(b)(2) regulatory pathway provides a streamlined approval process for modified versions of previously approved drugs, allowing pharmaceutical companies to rely partly on existing safety/efficacy data while still requiring new clinical data, commonly used across various therapeutic areas including reformulations, new dosage forms, and drug combinations.
Managing ADC Toxicities and Infusion Reactions With Supportive Care Strategies
March 20th 2025Panelists discuss how antibody-drug conjugates (ADCs) often cause toxic adverse events (AEs). Supportive care includes antiemetics, corticosteroids, and growth factors. Infusion reactions are managed with premedication and slow titration.
Strategies for Supporting Adherence to Treatment and Evaluating Efficacy
March 20th 2025Panelists discuss how health care professionals support medication adherence through personalized strategies, communication, and technological aids, while evaluating menopause therapy effectiveness via regular assessments, standardized tools, and comprehensive patient-centered approaches.
Patient Education When Initiating Treatment for Menopausal Symptoms
March 20th 2025Panelists note how medical professionals discuss menopause therapy, addressing symptoms, treatment options, safety concerns, adverse events, and personalized management strategies through patient-centered care. Professionals prioritize transparent communication, comprehensive risk assessment, and collaborative decision-making to ensure patient comfort and optimal management of menopausal transition.
Practical Insights for Pharmacists on ADC Administration, Patient Experience, and Supportive Care
March 20th 2025Panelists discuss how antibody-drug conjugates (ADCs) often show more diverse outcomes in real-world settings compared with clinical trials, with varying efficacy and adverse effect profiles. Key practical considerations for pharmacists include appropriate dosing based on patient factors, managing drug interactions, implementing premedication protocols to minimize adverse reactions, and providing comprehensive supportive care. Careful monitoring and individualized patient management are essential for optimal therapeutic outcomes.